COMPARISON OF MEAN GLYCATED HEMOGLOBIN (HBA1C) IN TYPE 2 DIABETIC HEPATITIS C (HCV) PATIENTS WITH SVR ACHIEVED VERSUS SVR NOT ACHIEVED FOLLOWING DIRECT ACTING ANTIVIRALS (DAAS) THERAPY. RMSR 2025, 3 (6), 94-100.